...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis of N-{4-[(2,4-Diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic Acid and N-{4-[(2-Amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic Acid as Dual Inhibitors of Dihyd
【24h】

Synthesis of N-{4-[(2,4-Diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic Acid and N-{4-[(2-Amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic Acid as Dual Inhibitors of Dihyd

机译:N- {4-[(2,4-二氨基-5-甲基-4,7-二氢-3H-吡咯并[2,3-d]嘧啶-6-基)硫代]苯甲酰基} -L-谷氨酸的合成和N- {4-[(2-氨基-4-氧代-5-甲基-4,7-二氢-3H-吡咯并[2,3-d]嘧啶-6-基)硫代]苯甲酰基} -L-谷氨酸酸作为二醛的双重抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Two novel classical antifolates N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]-pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid 3 and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid 4 were designed,synthesized,and evaluated as antitumor agents.Compounds 3 and 4 were obtained from 2,4-diamino-5-meth-ylpyrrolo[2,3-d]pyrimidine 7 and 2-amino-4-oxo-5-methylpyrrolo[2,3-d]pyrimidine 12,respectively,in a concise three-step sequence.Compound 3 is the first example,to our knowledge,of a 2,4-diamino classical antifolate that has potent inhibitory activity against both human dihydrofolate reductase(DHFR)and human thymidylate synthase(TS).Compound 4 was a dual DHFR-TS inhibitor against the bifunctional enzyme derived from Toxoplasma gondii(tg).Further evaluation of the mechanism of action of 3 implicated DHFR as its primary intracellular target.Both 3 and 4 were folylpolyglutamate synthetase(FPGS)substrates.Compound 3 also inhibited the growth of several human tumor cell lines in culture with GI_(50)< 10~(-8)M.This study shows that the pyrrolo[2,3-d]pyrimidine scaffold is conducive to dual DHFR-TS and tumor inhibitory activity,and the potency is determined by the 4-position substituent.
机译:两种新型经典抗叶酸剂N- {4-[(2,4-二氨基-5-甲基-4,7-二氢-3H-吡咯并[2,3-d]-嘧啶-6-基)硫代]苯甲酰基} -L -谷氨酸3和N- {4-[(2-氨基-4-氧代-5-甲基-4,7-二氢-3H-吡咯并[2,3-d]嘧啶-6-基)硫代]苯甲酰基}设计,合成并评价了-L-谷氨酸4作为抗肿瘤剂。由2,4-二氨基-5-甲基-吡咯并[2,3-d]嘧啶7和2-氨基-4获得化合物3和4。 -oxo-5-methylpyrrolo [2,3-d] pyrimidine 12分别以简洁的三步顺序进行。据我们所知,化合物3是具有有效抑制作用的2,4-二氨基经典抗叶酸药物的第一个实例。化合物4是针对弓形虫(tg)衍生的双功能酶的双重DHFR-TS抑制剂。化合物4是一种双重DHFR-TS抑制剂,可对抗弓形虫(tg)的双功能酶。它的主要细胞内靶标。3和4均为叶酰聚谷氨酸合成酶(FPGS)底物。化合物3也抑制了GI_(50)<10〜(-8)M培养的几种人类肿瘤细胞系的生长。本研究表明吡咯并[2,3-d]嘧啶支架有助于双重DHFR-TS和抑癌活性,效力由4位取代基决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号